Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.

Haddad RI, Nasr C, Bischoff L, Busaidy NL, Byrd D, Callender G, Dickson P, Duh QY, Ehya H, Goldner W, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, McIver B, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Sippel R, Smallridge RC, Sturgeon C, Wang TN, Wirth LJ, Wong RJ, Johnson-Chilla A, Hoffmann KG, Gurski LA.

J Natl Compr Canc Netw. 2018 Dec;16(12):1429-1440. doi: 10.6004/jnccn.2018.0089.

PMID:
30545990
2.

Combined administration of anti-IL-13 and anti-IL-17A at individually sub-therapeutic doses limits asthma-like symptoms in a mouse model of Th2/Th17 high asthma.

Kim D, McAlees JW, Bischoff LJ, Kaur D, Houshel LK, Gray J, Hargis J, Davis X, Dudas PL, Deshmukh H, Lewkowich IP.

Clin Exp Allergy. 2019 Mar;49(3):317-330. doi: 10.1111/cea.13301. Epub 2018 Nov 29.

PMID:
30353972
3.

Papillary-Type Carcinoma of the Thyroglossal Duct Cyst: The Case for Conservative Management.

Wood CB, Bigcas JL, Alava I, Bischoff L, Langerman A, Kim Y.

Ann Otol Rhinol Laryngol. 2018 Oct;127(10):710-716. doi: 10.1177/0003489418791892. Epub 2018 Aug 9.

PMID:
30091370
4.

Wnt Signaling in Thyroid Homeostasis and Carcinogenesis.

Ely KA, Bischoff LA, Weiss VL.

Genes (Basel). 2018 Apr 10;9(4). pii: E204. doi: 10.3390/genes9040204. Review.

5.

Liraglutide and Renal Outcomes in Type 2 Diabetes.

Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators.

N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011.

6.

Thyroid Cancer in Pregnancy.

Yu SS, Bischoff LA.

Semin Reprod Med. 2016 Nov;34(6):351-355. Epub 2016 Oct 14.

PMID:
27741551
7.

Management of Hyperthyroidism during the Preconception Phase, Pregnancy, and the Postpartum Period.

Sarkar S, Bischoff LA.

Semin Reprod Med. 2016 Nov;34(6):317-322. Epub 2016 Oct 14. Review.

PMID:
27741549
8.

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators.

N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13.

9.

Is above age 45 appropriate for upstaging well-differentiated papillary thyroid cancer?

Bischoff LA, Curry J, Ahmed I, Pribitkin E, Miller JL.

Endocr Pract. 2013 Nov-Dec;19(6):995-7. doi: 10.4158/EP13029.OR.

PMID:
24013977
10.

Exenatide once weekly in type 2 diabetes mellitus.

Bischoff LA, Jabbour SA, Miller JL.

Expert Opin Pharmacother. 2011 Jun;12(8):1297-1303. doi: 10.1517/14656566.2011.573145. No abstract available.

PMID:
21548720
11.

Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature.

Bischoff L, Derk CT.

Int J Dermatol. 2008 Jan;47(1):29-35. doi: 10.1111/j.1365-4632.2007.03544.x. Review.

PMID:
18173597
12.

Scleroderma lung disease: treatment with cyclophosphamide.

Schulz S, Bischoff L, Michel D, Derk CT.

Expert Rev Clin Immunol. 2006 Nov;2(6):849-52. doi: 10.1586/1744666X.2.6.849.

PMID:
20476972
13.

The physician-hospital team: a successful approach to improving care in a large academic medical center.

Feldman AM, Weitz H, Merli G, DeCaro M, Brechbill AL, Adams S, Bischoff L, Richardson R, Williams MJ, Wenneker M, Epstein A.

Acad Med. 2006 Jan;81(1):35-41.

PMID:
16377816

Supplemental Content

Loading ...
Support Center